Patents by Inventor John Butera

John Butera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] Phosphonic Acid and Methods of Use Thereof
    Publication number: 20070225257
    Abstract: Compounds of formula (I) or pharmaceutically acceptable salts thereof are provided where at least one of R2 or R3 is not hydrogen. The compounds of the present invention are N-methyl-D-aspartate (NMDA) receptor antagonists and are useful in treating a variety of conditions present in a mammal that benefit from inhibiting the NMDA receptor.
    Type: Application
    Filed: June 1, 2007
    Publication date: September 27, 2007
    Applicant: Wyeth
    Inventors: Reinhardt Baudy, John Butera
  • Modified lysine-mimetic compounds
    Publication number: 20070149460
    Abstract: Lysine mimetic compounds having useful pharmacological activity such as antiarrhythmic activity and desirable bioavailability properties are disclosed.
    Type: Application
    Filed: December 21, 2006
    Publication date: June 28, 2007
    Inventors: Bjarne Larsen, Jorgen Petersen, Ketil Haugan, John Butera, James Hennan, Edward Kerns, Evgueni Piatnitski
  • Substituted benzofuran oximes
    Publication number: 20050215626
    Abstract: The present invention relates to substituted benzofuran oximes and methods of using them.
    Type: Application
    Filed: September 23, 2004
    Publication date: September 29, 2005
    Applicant: WYETH
    Inventors: Lisa Havran, John Butera, Hassan Elokdah, Douglas Jenkins, Eric Gundersen
  • Substituted aryloximes
    Publication number: 20050119326
    Abstract: The present invention relates to substituted indole oximes and methods of using them.
    Type: Application
    Filed: September 23, 2004
    Publication date: June 2, 2005
    Applicant: WYETH
    Inventors: Lisa Havran, John Butera, Hassan Elokdah, Douglas Jenkins, Eric Gundersen
  • Substituted aryloximes
    Publication number: 20050070584
    Abstract: The present invention relates to substituted aryl oximes and methods of using them.
    Type: Application
    Filed: September 23, 2004
    Publication date: March 31, 2005
    Applicant: WYETH
    Inventors: Lisa Havran, John Butera, Hassan Elokdah, Douglas Jenkins, Eric Gundersen
  • 3-Amino chroman and 2-amino tetralin derivatives
    Publication number: 20050032873
    Abstract: 3-Amino chroman and 2-amino tetralin derivatives and compositions containing such compounds are disclosed. Methods of using the 3-amino chroman and 2-amino tetralin compounds and compositions containing such compounds in the treatment of serotonin disorders, such as depression and anxiety, are also disclosed.
    Type: Application
    Filed: July 26, 2004
    Publication date: February 10, 2005
    Applicant: Wyeth
    Inventors: Nicole Hatzenbuhler, Deborah Evrard, Richard Mewshaw, Dahui Zhou, Uresh Shah, Jennifer Inghrim, Steven Lenicek, Reinhardt Baudy, John Butera, Annmarie Sabb, Amedeo Failli, Pudukkaraipudur Ramamoorthy
  • Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and methods of use thereof
    Publication number: 20050004080
    Abstract: Compounds of formula (I) or pharmaceutically acceptable salts thereof are provided where at least one of R2 or R3 is not hydrogen. The compounds of the present invention are N-methyl-D-aspartate (NMDA) receptor antagonists and are useful in treating a variety of conditions present in a mammal that benefit from inhibiting the NMDA receptor.
    Type: Application
    Filed: April 7, 2004
    Publication date: January 6, 2005
    Applicant: Wyeth
    Inventors: Reinhardt Baudy, John Butera